Literature DB >> 27090897

[Course of rehabilitation in early neurological/neurosurgical rehabilitation. Results of a 2014 multi-center evaluation in Germany].

M Pohl1,2, M Bertram3, C Bucka4, M Hartwich5, M Jöbges6, G Ketter7, B Leineweber8, M Mertl-Rötzer9, D A Nowak10, T Platz11, J D Rollnik12, K Scheidtmann13, R Thomas14, F von Rosen15, C W Wallesch16, H Woldag17, P Peschel18, J Mehrholz19.   

Abstract

BACKGROUND: In Germany, neurological-neurosurgical early rehabilitation is well established in the treatment of severe neurological diseases. To develop quality standards, knowledge of the current rehabilitation course is required. PATIENTS AND METHODS: A retrospective analysis was performed on the course of rehabilitation from patients in an early neurological/neurosurgical rehabilitation program in 16 centers from 10 German states. The odds for a good or poor outcome were investigated using a multivariate logistic regression model.
RESULTS: Seven hundred and fifty-four patients were included in the study. The average age of the patients was 68 ± 15 years. Of the patients studied, 26 % were on mechanical ventilation commencing their neurological rehabilitation. The average duration of stay was 56 ± 51 days. Weaning rate from mechanical ventilation was 65 % and the rate of weaning from tracheal cannula was 54 %. Mean improvement in the Barthel Index of 17 points, significant reduction of dysphagia (from 62 to 30 %) and depended walking (from 99 to 82 %), and the achievement of phase C (the next stage of rehabilitation) in 38 % can still be counted as signs of successful rehabilitation. During their course of stay, near 10 % of the patients died. Of these, 67 % received solely palliative care. In the multivariate logistic models, the absence of the factor "necessity for mechanical ventilation on admission" (odds ratio 0.61; 95 % confidence interval (CI): 0.42 … 0.89) increased the chance for good outcome and the presence of this factor the risk of dying with an odds ratio of 8.07 (95 % CI: 4.54-14.34). DISCUSSION: In spite of the severity of neurological deficits, significant functional progress has been made. These results could be interpret as positive proof of the efficacy of neurological/neurosurgical early rehabilitation programs.

Entities:  

Keywords:  Barthel index; Early neurological and neurosurgical rehabilitation; Long-term rehabilitation course; Neurological rehabilitation Phase B

Mesh:

Year:  2016        PMID: 27090897     DOI: 10.1007/s00115-016-0093-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  16 in total

1.  Repetitive locomotor training and physiotherapy improve walking and basic activities of daily living after stroke: a single-blind, randomized multicentre trial (DEutsche GAngtrainerStudie, DEGAS).

Authors:  M Pohl; C Werner; M Holzgraefe; G Kroczek; J Mehrholz; I Wingendorf; G Hoölig; R Koch; S Hesse
Journal:  Clin Rehabil       Date:  2007-01       Impact factor: 3.477

Review 2.  [Early neurological-neurosurgical rehabilitation. Current state].

Authors:  M Bertram; T Brandt
Journal:  Nervenarzt       Date:  2007-10       Impact factor: 1.214

3.  [The rehabilitation of patients who are (still) unfit for rehabilitation].

Authors:  C- W Wallesch
Journal:  Fortschr Neurol Psychiatr       Date:  2015-05-27       Impact factor: 0.752

4.  Long-term outcome in the North East Melbourne Stroke Incidence Study: predictors of quality of life at 5 years after stroke.

Authors:  Seana L Paul; Jonathan W Sturm; Helen M Dewey; Geoffrey A Donnan; Richard A L Macdonell; Amanda G Thrift
Journal:  Stroke       Date:  2005-09-22       Impact factor: 7.914

5.  [Application of a sponaneous ventilation protocol. Experiences from a weaning center for neurological diseases].

Authors:  F Oehmichen; K Zäumer; M Ragaller; J Mehrholz; M Pohl
Journal:  Nervenarzt       Date:  2013-08       Impact factor: 1.214

6.  Current trends in the length of stay in neurological early rehabilitation.

Authors:  Jens D Rollnik; Uwe Janosch
Journal:  Dtsch Arztebl Int       Date:  2010-04-23       Impact factor: 5.594

7.  [Long-term course of patients in neurological rehabilitation Phase B. Results of the 6-year follow-up in a multicenter study].

Authors:  M Pohl; K Berger; G Ketter; C Krusch; M Pause; W Puschendorf; M Schaupp; J Schleep; M Spranger; D Steube; K Scheidtmann; J Mehrholz
Journal:  Nervenarzt       Date:  2011-06       Impact factor: 1.214

8.  Survival and outcome of neurosurgical patients requiring ventilatory support after intensive care unit stay.

Authors:  Kirsi Malmivaara; Juha Hernesniemi; Ritva Salmenperä; Juha Ohman; Risto P Roine; Jari Siironen
Journal:  Neurosurgery       Date:  2009-09       Impact factor: 4.654

9.  [The Early Rehabilitation Barthel Index--an early rehabilitation-oriented extension of the Barthel Index].

Authors:  P W Schönle
Journal:  Rehabilitation (Stuttg)       Date:  1995-05       Impact factor: 1.113

10.  First results about recovery of walking function in patients with intensive care unit-acquired muscle weakness from the General Weakness Syndrome Therapy (GymNAST) cohort study.

Authors:  Jan Mehrholz; Simone Mückel; Frank Oehmichen; Marcus Pohl
Journal:  BMJ Open       Date:  2015-12-23       Impact factor: 2.692

View more
  12 in total

1.  [A phase model of trauma rehabilitation : How can we avoid the "rehab-hole"?]

Authors:  Stefan Simmel; Wolf-Dieter Müller; Christoph Reimertz; Christian Kühne; Jean-Jacques Glaesener
Journal:  Unfallchirurg       Date:  2017-09       Impact factor: 1.000

Review 2.  [Prolonged weaning during early neurological and neurosurgical rehabilitation : S2k guideline published by the Weaning Committee of the German Neurorehabilitation Society (DGNR)].

Authors:  J D Rollnik; J Adolphsen; J Bauer; M Bertram; J Brocke; C Dohmen; E Donauer; M Hartwich; M D Heidler; V Huge; S Klarmann; S Lorenzl; M Lück; M Mertl-Rötzer; T Mokrusch; D A Nowak; T Platz; L Riechmann; F Schlachetzki; A von Helden; C W Wallesch; D Zergiebel; M Pohl
Journal:  Nervenarzt       Date:  2017-06       Impact factor: 1.214

3.  [Weaning concepts in the setting of neurological disorders].

Authors:  M Hartwich
Journal:  Nervenarzt       Date:  2017-10       Impact factor: 1.214

4.  [Telerehabilitation can not replace traditional neurological rehabilitation].

Authors:  J D Rollnik; M Pohl; T Mokrusch; C W Wallesch
Journal:  Nervenarzt       Date:  2017-10       Impact factor: 1.214

5.  [Integrated neurorehabilitation improves efficacy of treatment].

Authors:  Stefan Knecht; Bettina Studer
Journal:  Nervenarzt       Date:  2019-04       Impact factor: 1.214

6.  [Predictors of cognitive outcome in ventilated early rehabilitation patients].

Authors:  M-D Heidler; L Bidu; H Völler; A Salzwedel
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

Review 7.  [Out-of-hospital ventilation after prolonged weaning].

Authors:  K Fricke; B Schönhofer
Journal:  Pneumologe (Berl)       Date:  2020-11-16

8.  One-year outcome of brain injured patients undergoing early neurological rehabilitation: a prospective observational study.

Authors:  Melanie Boltzmann; Simone B Schmidt; Christoph Gutenbrunner; Joachim K Krauss; Günter U Höglinger; Jens D Rollnik
Journal:  BMC Neurol       Date:  2022-01-17       Impact factor: 2.474

9.  Criterion validity and sensitivity to change of the Early Rehabilitation Index (ERI): results from a German multi-center study.

Authors:  Jens D Rollnik; M Bertram; C Bucka; M Hartwich; M Jöbges; G Ketter; B Leineweber; M Mertl-Rötzer; D A Nowak; T Platz; K Scheidtmann; R Thomas; F von Rosen; C W Wallesch; H Woldag; P Peschel; J Mehrholz; M Pohl
Journal:  BMC Res Notes       Date:  2016-07-21

10.  Decannulation of tracheotomized patients after long-term mechanical ventilation - results of a prospective multicentric study in German neurological early rehabilitation hospitals.

Authors:  Maria-Dorothea Heidler; Annett Salzwedel; Michael Jöbges; Olaf Lück; Christian Dohle; Michael Seifert; Andrea von Helden; Wibke Hollweg; Heinz Völler
Journal:  BMC Anesthesiol       Date:  2018-06-13       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.